参考文献/References:
[1] Groot D, John F. High-grade gliomas [J]. Continuum: Life-long Learning Neurol, 2015, 21: 332-344.
[2] Li XQ, Ouyang ZG, Zhang SH, et al. Synergistic inhibition of angiogenesis and glioma cell-induced angiogenesis by the combination of temozolomide and enediyne antibiotic lidamycin [J]. Cancer Biol Ther, 2014, 15(4): 398-408.
[3] 陈正和，陈忠平. 高级别胶质瘤的治疗现状及思考[J]. 中国临床神经外科杂志，2016，21（6）：350-352.
[4] 赛 克，陈忠平. 胶质瘤的疗效评价[J]. 中国临床神经外科杂志，2016，21（6）：321-322.
[5] Westphal M, Lamszus K. Circulating biomarkers for gliomas [J]. Nat Rev Neurol, 2015, 11(10): 556-566.
[6] Toss A, Mu Z, Fernandez S, et al. CTC enumeration and characterization: moving toward personalized medicine [J]. Ann Transl Med, 2014, 2(11): 108.
[7] Macarthur KM, Kao GD, Chandrasekaran S, et al. Detection of brain tumor cells in the peripheral blood by a telomerase promoter-based assay [J]. Cancer Res, 2014, 74(8): 2152-2159.
[8] Muller C, Holtschmidt J, Auer M, et al. Hematogenous dis-semination of glioblastoma multiforme [J]. Sci Transl Med, 2014, 6(247): 247ra101.
[9] Redzic JS, Ung TH, Graner MW, et al. Glioblastoma extra-cellular vesicles: reservoirs of potential biomarkers [J]. Pharmgenomics Pers Med, 2014, 7: 65-77.
[10] Belting M, Christianson HC. Role of exosomes and microve-sicles in hypoxiaassociatedtumour development and cardio-vascular disease [J]. Intern Med, 2015, 278(3): 251-263.
[11] Muller L, Muller HS, Mitsuhashi M, et al. Exosomes isolated from plasma of glioma patients enrolled in a vaccination trial reflect antitumor immune activity and might predict survival [J]. Oncoimmunology, 2015, 4(6): e1008347.
[11] Shao H, Chung J, Lee K, et al. Chip-based analysis of exo-somal mRNA mediating drug resistance in glioblastoma [J]. Nat Commun, 2015, 6: 6999.
[12] 林昌海，李丽仙，冉 静，等. 脑胶质瘤血液循环肿瘤标志物研究进展[J]. 重庆医学，2016，45（30）：4293-4296.
[13] Popescu ID, Codrici E, Albulescu L, et al. Potential serum biomarkers for glioblastoma diagnostic assessed by proteo-mic approaches [J]. Proteome Sci, 2014, 12(1): 47.
[14] Gollapalli K, Ray S, Srivastava R, et al. Investigation of serum proteome alterations in human glioblastoma multifor-me [J]. Proteomics, 2012, 12(14): 2378-2390.
[16] Floyd D, Purow B. Micro-masters of glioblastoma biology and therapy: increasingly recognized roles for microRNAs [J]. Neuro Oncol, 2014, 16(5): 622-627.
[17] 刘 征，徐国政. 胶质瘤相关循环生物标志物的研究进展[J].中国临床神经外科杂志，2017，22（3）：201-203.
[18] Godlewski J, Krichevsky AM, Johnson MD, et al. Belonging to a network-microRNAs, extracellular vesicles, and the glioblastoma microenvironment [J]. Neuro Oncol, 2015, 17(5):147-158.
[19] 赵建辉，胡世颉，费 舟. miRNA在胶质瘤临床诊疗中的研究进展[J]. 中国临床神经外科杂志，2016，21（10）：642-645.
[20] Li R, Gao K, Luo H, et al. Identification of intrinsic sub-type-specific prognostic microRNAs in primary glioblastoma [J]. Exp Clin Cancer Res, 2014, 33(1): 9.
[21] Chen H, Li X, Li W, et al. miR-130a can predict response to temozolomide in patients with glioblastoma multiforme, independently of O6-methylguanine-DNA methyltrans-ferase [J]. Transl Med, 2015, 13(1), 69.
[22] Kushwaha D, Ramakrishnan V, NgK, et al. A genome-wide miRNA screen revealed miR-603 as a MGMT-regulating miRNA in glioblastomas [J]. Oncotarget, 2014, 5(12): 4026-4039.
[23] Zhang W, Zhang J, Hoadley K, et al. miR-181d: a predic-tive glioblastoma biomarker that downregulates MGMT expression [J]. Neuro Oncol, 2012, 14(6): 712-719.
[24] Qu S, Guan J, Liu Y. Identification of microRNAs as novel biomarkers for glioma detection: a meta-analysis based on 11 articles [J]. Neurol Sci, 2015, 348(1-2): 181-187.
[25] Francis G, Stein S. Circulating cell-free tumour DNA in themanagement of cancer [J]. Int J Mol Sci, 2015, 16(6): 14122.
[26] Lebofsky R, Decraene C, Bernard V, et al. Circulating tumor DNA as a non-invasive substitute to metastasis biopsy for tumor genotyping and personalized medicine in a prospec-tive trial across all tumor types [J]. Mol Oncol, 2014, 9(4): 783-790.
[27] Wang WY, Twu CW, Chen HH, et al. Plasma EBV DNA clearance rate as a novel prognostic marker for metastatic/recurrent nasopharyngeal carcinoma [J]. Clin Cancer Res, 2010, 16(3): 1016-1024.
[28] Boisselier B, Gallego PJ, Rossetto M, et al. Detection of IDH1 mutation in?the plasma of patients with glioma [J]. Neurology, 2012, 79(16): 1693-1698.
相似文献/References:
[1]付 锴 江普查 宫 睿 王 伟.表达VASH1基因的人脑胶质瘤U-87MG细胞对化疗药物敏感性的变化[J].中国临床神经外科杂志,2016,(01):34.[doi:10.13798/j.issn.1009-153X.2016.01.012]
FU Kai,JIANG Pu-cha,GONG Rui,et al.Effect of lentiviral vector-mediated VASH1 gene on chemosensitivity of human glioma U-87MG cells[J].,2016,(12):34.[doi:10.13798/j.issn.1009-153X.2016.01.012]
[2]崔焕喜,柳 琛.多模态MRI、神经导航和超声在脑胶质瘤术中的应用[J].中国临床神经外科杂志,2016,(11):721.[doi:10.13798/j.issn.1009-153X.2016.11.027]
[3]闫 珊 徐善才.多学科护理照顾模式对脑胶质瘤术后病人自我护理能力的影响[J].中国临床神经外科杂志,2017,(05):352.[doi:10.13798/j.issn.1009-153X.2017.05.026]
YAN Shan,XU Shan-cai..Effects of multi-subjects nursing care model on self-care ability in patients with brain glioma after operation[J].,2017,(12):352.[doi:10.13798/j.issn.1009-153X.2017.05.026]
[4]罗似亮 夏之柏.脑胶质瘤病人脑脊液Midkine表达的临床意义[J].中国临床神经外科杂志,2017,(06):416.[doi:10.13798/j.issn.1009-153X.2017.06.017]
LUO Si-liang,XIA Zhi-bo..Clinical meanings of midkine expression in cerebrospinal fluid of patients with gliomas[J].,2017,(12):416.[doi:10.13798/j.issn.1009-153X.2017.06.017]
[5]呼铁民 褚会松 田 甜 王昆鹏 杨国军 杨立军 王维兴.脑胶质瘤ADAM17与EGFR的表达及临床意义[J].中国临床神经外科杂志,2017,(08):557.[doi:10.13798/j.issn.1009-153X.2017.08.012]
HU Tie-min,CHU Hui-song,TIAN Tian,et al.Expressions of ADAM17 and EGFR in gliomas tissues and their clinical meanings[J].,2017,(12):557.[doi:10.13798/j.issn.1009-153X.2017.08.012]
[6]汪超甲 综述 王 辉 审校.脑胶质瘤化疗现状及耐药机制的研究进展[J].中国临床神经外科杂志,2017,(11):791.[doi:10.13798/j.issn.1009-153X.2017.11.023]
[7]高剑峰 姚庆和 李晓辉 龙宇波 陈振波.脑胶质瘤miR-9、PPARγ表达水平及临床意义[J].中国临床神经外科杂志,2018,(01):17.[doi:10.13798/j.issn.1009-153X.2018.01.006]
GAO Jian-feng,YAO Qing-he,LI Xiao-hui,et al.Expressions of miR-9 and PPARγ in human brain gliomas and their clinical meanings[J].,2018,(12):17.[doi:10.13798/j.issn.1009-153X.2018.01.006]
[8]刘 靖 吴立权 黄书岚.聚焦解决模式对脑胶质瘤术后病人自我管理效能感及生命意义的影响[J].中国临床神经外科杂志,2018,(03):208.[doi:10.13798/j.issn.1009-153X.2018.03.025]
LIU Jing,WU Li-quan,HUANG Shu-lan..Effects of solution focused intervention on self-management efficacy and meanings of life in the patients with gliomas after surgery[J].,2018,(12):208.[doi:10.13798/j.issn.1009-153X.2018.03.025]
[9]刘 炎 杭春华.脑胶质瘤卒中误诊为脑动静脉畸形并出血1例[J].中国临床神经外科杂志,2018,(06):448.[doi:10.13798/j.issn.1009-153X.2018.06.025]
[10]刘东明 胡新华 刘 永 陈 玖 刘宏毅.脑胶质瘤病人静息态默认模式网络研究进展[J].中国临床神经外科杂志,2018,(12):821.[doi:10.13798/j.issn.1009-153X.2018.12.022]